Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06710847 |
| Title | A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors (SYLVER) |
| Acronym | SYLVER |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | RECRUITING | Denver | Colorado | 80218 | United States | Details |
| GSK Investigational Site | RECRUITING | Chiba | 277-8577 | Japan | Details | |
| GSK Investigational Site | RECRUITING | Tokyo | 104-0045 | Japan | Details | |
| GSK Investigational Site | RECRUITING | Tokyo | 135-8550 | Japan | Details |